Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Pros & Cons of Combining Different Specialties Under One Roof

Gregory C. Gardner, MD, FACP  |  Issue: July 2018  |  July 19, 2018

There is limited written experience regarding combined clinics in other fields that include rheumatology, and although the literature on combined clinics often suggests benefits to education, no actual data on this aspect appear to exist.

Cons

Challenges have been documented in the literature regarding combined clinics, and we have had our issues as well, such as scheduling. In my ILD/rheumatology clinic, all my patients are combined, but the three ILD pulmonologists have other patients on their schedules. Occasionally, patients needing a combined visit must wait to see both based on the schedule of the pulmonologist. This issue is easiest to handle at clinics employing the different-specialists, same-time strategy.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Productivity is an issue, too. Dermatologists usually see 12–15 patients in a half day while we academic rheumatologists see about half that. On the flip side, patients referred to a combined clinic are usually more complex and, thus, billing is at a higher level.

Billing can prove challenging as well, with most providers billing via their respective service centers. Thus, patients may see two bills.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We have seen turf wars among support staff. For example, if a patient needs a medication preauthorized, which clinic is responsible? The clinic where we spend the most time in general rheumatology, the clinic with experience doing preauthorizations for immunosuppressive medications or the clinic we attend once a month or once a week as part of the combined clinic? We finally divided and conquered by having the combined-clinic staff handle the oral medications and the rheumatology clinic staff handle the biologics and infusions. Diplomacy skills are definitely needed in such situations.

Finally, institutional buy-in is important to obtain the needed space and support staff to make it all work. Combined clinics can be a local or regional draw to the institution, and I suspect they have a favorable downstream revenue profile even though the institution may remain reluctant to admit it.

Final Thoughts

Personally and professionally, I find working in combined clinic settings one of the highlights of my career. Thinking about patients using different specialist eyes has broadened my horizons and has helped me look outside my rheumatology box.

I recently spent two weeks in Saipan as a visiting professor, and the lessons I’d learned from my combined clinic colleagues back home helped me be more useful to the patients and clinicians of the island. I saw several patients with complex psoriasis and a patient or two with ILD. No problem; I knew what to do. All I had to do was ask myself, “What would Dr. Kalus (our derma­tologist) or Dr. Ho (our pulmonologist) do in this situation?”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:FacilityPractice SupportWorkforce Tagged with:specialty

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease

    September 22, 2021

    Treatment with tocilizimab preserved lung function in patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) regardless of a patient’s level of lung involvement, according to a recent study.

    New Africa / shutterstock.com

    A Rheumatologist & Pulmonologist Discuss RA-ILD

    November 14, 2021

    Introduction The understanding and treatment of rheuma­toid arthritis (RA) has evolved dramatically in the past 20 years. As gains have been made in treating joint disease in RA, our understanding of the impact of extra-articular manifestations of RA, such as cardiac and lung disease—specifically interstitial lung disease (ILD)—has gradually increased. While rheumatologists increasingly appreciate the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences